Butler K D, Shand R A, Wallis R B
Thromb Haemost. 1986 Dec 15;56(3):263-7.
The effects of intravenously administered collagen on the circulatory platelet count, TxB2, 6-keto PGF1 alpha and 51Cr-labelled platelet accumulation in the thorax have been evaluated in the guinea-pig. Administration of collagen induced a dose-related peripheral thrombocytopenia and a concomitant increase in 51Cr-labelled platelets in the thorax. There was also a transient dose-related increase in plasma TxB2 but no change in plasma 6-keto PGF1 alpha levels. The thromboxane synthetase inhibitors tested, reduced the platelet accumulation, but only CGS 13080 significantly inhibited TxB2 production. In contrast all the cyclooxygenase inhibitors tested impaired the elevation of plasma TxB2 after collagen, but only diclofenac inhibited the 51Cr-labelled platelet accumulation. The greater effect of thromboxane synthetase inhibitors compared to cyclooxygenase inhibitors on platelet accumulation in this system cannot be completely explained by the changes measured in the circulating prostanoids.
在豚鼠中评估了静脉注射胶原蛋白对循环血小板计数、血栓素B2(TxB2)、6-酮-前列腺素F1α(6-keto PGF1 alpha)以及胸部51铬标记血小板聚集的影响。给予胶原蛋白会引起剂量相关的外周血小板减少以及胸部51铬标记血小板的相应增加。血浆TxB2也会出现短暂的剂量相关增加,但血浆6-酮-前列腺素F1α水平无变化。所测试的血栓素合成酶抑制剂可减少血小板聚集,但只有CGS 13080能显著抑制TxB2的产生。相比之下,所有测试的环氧化酶抑制剂都会削弱胶原蛋白注射后血浆TxB2的升高,但只有双氯芬酸能抑制51铬标记血小板的聚集。在该系统中,血栓素合成酶抑制剂相较于环氧化酶抑制剂对血小板聚集的影响更大,这无法完全通过循环前列腺素的测量变化来解释。